FDA 批准 Dexcom 的 Stelo CGM 作为非处方药使用，首先无需处方即可用于 18 岁以上的非胰岛素使用者。 FDA clears Dexcom's Stelo CGM for OTC use, first without prescription for non-insulin users aged 18+.
FDA 已批准 Dexcom 的 Stelo 葡萄糖生物传感器系统用于非处方药 (OTC)，这标志着它成为首款无需处方即可使用的连续血糖监测仪 (CGM)。 The FDA has cleared Dexcom's Stelo Glucose Biosensor System for over-the-counter (OTC) use, marking it as the first continuous glucose monitor (CGM) available without a prescription. Stelo 专为 18 岁及以上不使用胰岛素的个人设计，包括那些接受口服药物治疗的糖尿病患者或那些寻求更好地了解饮食和运动如何影响血糖水平的未患糖尿病的患者。 Stelo is designed for individuals aged 18 years and older who do not use insulin, including those with diabetes treated with oral medications or those without diabetes seeking to better understand how diet and exercise affect blood sugar levels. 该设备不适用于使用胰岛素的糖尿病患者或患有低血糖问题的个人。 The device is not intended for diabetics who use insulin or for individuals with problematic hypoglycemia.